Are you Dr. Arkadir?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
120 W 73rd St
Apt 3a
New York, NY 10023Phone+1 347-216-8118
Clinical Trials
- Safety, Tolerability and Effects of Mannitol in Parkinson's Disease Start of enrollment: 2018 Nov 20
Publications & Presentations
PubMed
- 1 citationsReader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.Montaser Namnah, Orly Elpeleg, Marc Gotkine, David Arkadir
Neurology. 2020-05-26 - 23 citationsLong Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher DiseaseTama Dinur, Ari Zimran, Michal Becker-Cohen, David Arkadir, Claudia Cozma
Journal of Clinical Medicine. 2019-10-11 - 47 citationsRedundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson diseaseDavid Arkadir, Hagai Bergman, Stanley Fahn
Neurology. 2014-03-25
Press Mentions
Mannitol Safe but Not Likely to Treat Parkinson’s Symptoms, Trial ReportsFebruary 4th, 2022- Cite Parkinson’s Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic ModifiersJanuary 1st, 2021
- The Science Behind Mannitol: How a Simple Sweetener May Help Parkinson’s PatientsJuly 29th, 2020
- Join now to see all
